Oncogenic Function of ATDC in Bladder Cancer
ATDC 在膀胱癌中的致癌功能
基本信息
- 批准号:9017959
- 负责人:
- 金额:$ 44.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-10 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:Ataxia-Telangiectasia Group D ComplementingBindingBiological ModelsBiologyBladderBladder NeoplasmBladder UrotheliumDNA DamageDNA MethylationDNMT3aDataDevelopmentDiseaseEventGene Expression ProfilingGenesHealthHereditary DiseaseHumanHuman Cell LineInflammationLeadMalignant NeoplasmsMalignant neoplasm of urinary bladderMediatingMethylationMolecularNeoplasm MetastasisOncogenesOncogenicOrganPTEN genePenetrancePrognostic MarkerRB1 geneRadiationResistanceRoleSamplingSignal TransductionTP53 geneTherapeuticTissuesTransgenic MiceTransgenic ModelTumor Suppressor GenesUp-RegulationUrotheliumbasebeta catenincancer initiationcancer riskchemotherapycytotoxicimprovedmouse modelnew therapeutic targetnoveloverexpressionpromoterresponsetumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Bladder cancer is a common and deadly disease, but the molecular events leading to its development are incompletely understood. We have recently identified a novel oncogene, Ataxia-Telangiectasia Group D Complementing (ATDC), which drives initiation and progression of bladder tumors in transgenic mice. These tumors are indistinguishable from their human counterparts. ATDC expression is elevated (about 70%) in human invasive bladder cancers and correlates with poorer survival after chemotherapy. In other tumor types, ATDC binds p53, modulates DNA damage responses and up-regulates beta-catenin signaling. In preliminary data, we find that ATDC expression is induced by inflammation, associated with decreased expression of PTEN and RB1, two important tumor suppressor genes implicated in bladder tumorigenesis, and show that ATDC promotes methylation and silencing of the PTEN promoter through upregulation of DNMT3a. We hypothesize that ATDC is a crucial determinant of formation, progression and the cytotoxic response in bladder cancer. To better understand the role of ATDC in bladder cancer, we propose the following studies: AIM 1: To characterize the role of ATDC in bladder cancer initiation, progression and metastasis using novel transgenic mouse models and determine the role of inflammation in inducing ATDC expression in normal urothelium. AIM 2: To characterize the role of PTEN, RB1 and p53 in ATDC-mediated bladder tumor formation and progression using both human and mouse model systems. AIM 3: To determine if ATDC expression in bladder cancer drives progression to invasive disease. AIM 4: To determine if ATDC expression promotes bladder tumor resistance to chemotherapy. These studies will characterize a novel mechanism of bladder tumor development and a valuable transgenic model of bladder cancer. We will also use existing human cell lines and primary human tumor samples to elucidate the molecular mechanisms by which ATDC induces bladder cancer and mediates resistance to chemotherapy. These studies are significant because understanding ATDC's oncogenic activity in bladder cancer may lead to new prognostic biomarkers and improved therapeutic approaches in humans.
描述(申请人提供):膀胱癌是一种常见的致命疾病,但导致其发展的分子事件尚不完全清楚。我们最近发现了一个新的癌基因,共济失调-毛细血管扩张症D组互补(ATDC),它在转基因小鼠中驱动膀胱肿瘤的发生和发展。这些肿瘤与人类的同类肿瘤难以区分。ATDC在人类浸润性膀胱癌中的表达升高(约70%),并与化疗后较差的生存期有关。在其他类型的肿瘤中,ATDC结合P53,调节DNA损伤反应,并上调β-连环蛋白信号。在初步数据中,我们发现ATDC的表达是由炎症诱导的,与PTEN和RB1这两个与膀胱肿瘤发生有关的重要抑癌基因的表达降低有关,并表明ATDC通过上调DNMT3a促进PTEN启动子的甲基化和沉默。我们假设ATDC是膀胱癌形成、发展和细胞毒反应的关键决定因素。为了更好地了解ATDC在膀胱癌中的作用,我们提出了以下研究:目的1:利用新型转基因小鼠模型,研究ATDC在膀胱癌发生、发展和转移中的作用,并确定炎症在诱导正常尿路上皮细胞ATDC表达中的作用。目的:利用人和小鼠膀胱肿瘤模型系统研究PTEN、RB1和P53在ATDC介导的膀胱肿瘤形成和发展中的作用。目的3:确定ATDC在膀胱癌中的表达是否推动了浸润性疾病的进展。目的4:探讨ATDC的表达是否促进了膀胱癌的化疗耐药。这些研究将表征一种新的膀胱癌发生机制和一种有价值的膀胱癌转基因模型。我们还将使用现有的人类细胞系和原代人类肿瘤样本来阐明ATDC诱导膀胱癌和介导化疗耐药的分子机制。这些研究意义重大,因为了解ATDC在膀胱癌中的致癌活性可能会导致新的预后生物标志物和人类治疗方法的改进。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIANE M SIMEONE其他文献
DIANE M SIMEONE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIANE M SIMEONE', 18)}}的其他基金
Biomarker Validation in Pancreatic Cystic Neoplasms
胰腺囊性肿瘤的生物标志物验证
- 批准号:
10722347 - 财政年份:2023
- 资助金额:
$ 44.43万 - 项目类别:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
HR 缺陷型胰腺癌中的 POLQ 综合致死率
- 批准号:
10218126 - 财政年份:2020
- 资助金额:
$ 44.43万 - 项目类别:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
HR 缺陷型胰腺癌中的 POLQ 综合致死率
- 批准号:
10442427 - 财政年份:2020
- 资助金额:
$ 44.43万 - 项目类别:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
HR 缺陷型胰腺癌中的 POLQ 综合致死率
- 批准号:
10656484 - 财政年份:2020
- 资助金额:
$ 44.43万 - 项目类别:
2015 Pancreatic Diseases Gordon Research Conference
2015年胰腺疾病戈登研究会议
- 批准号:
8970783 - 财政年份:2015
- 资助金额:
$ 44.43万 - 项目类别:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
项目3:lncRNA SNHG1和ATG7在基底亚型肌侵袭性膀胱肿瘤发生中的作用
- 批准号:
10661067 - 财政年份:2013
- 资助金额:
$ 44.43万 - 项目类别:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
项目3:lncRNA SNHG1和ATG7在基底亚型肌侵袭性膀胱肿瘤发生中的作用
- 批准号:
10229414 - 财政年份:2013
- 资助金额:
$ 44.43万 - 项目类别:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
项目3:lncRNA SNHG1和ATG7在基底亚型肌侵袭性膀胱肿瘤发生中的作用
- 批准号:
10455731 - 财政年份:2013
- 资助金额:
$ 44.43万 - 项目类别:
P4 - ATDC as a Therapeutic Target in Pancreatic Cancer
P4 - ATDC 作为胰腺癌的治疗靶点
- 批准号:
7893337 - 财政年份:2010
- 资助金额:
$ 44.43万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 44.43万 - 项目类别:
Discovery Projects